ResearchMoz

Companion Diagnostics and Personalized Medicine Market Report 2012

Publisher Name » Select Biosciences
Published Date » 2012-08-22
No. Of Pages » 130

This is the latest and most up-to-date Market Report from Select Biosciences addressing the companion diagnostics (CDx) and personalized medicine marketplace.Personalized medicine is a broad field with several stakeholders all of which must be aligned in order to capture the immense potential value in targeting therapeutics to the correct patient population—the field of stratified medicine.

Companion Diagnostics has been rapidly expanding over the past 3 years and in this market report we describe the current state of the marketplace from the following perspectives:

  • All the Prognostic and Predictive Biomarkers with Potential Clinical Utility are described—a few have already been developed into CDx and we expect growth in this space
  • Targeted Therapeutics, Associated Biomarkers, Therapeutic Indications, and Testing Mandates are Described
  • Companion Diagnostics Partnerships and Collaborations from 2009 to 2012 are Presented—Provides an Up-to-Date State of the Industry Describing the Disease Areas being Addressed and Types of Biomarkers Being Deployed
  • Quantitative Market Metrics
  • Quantitative Market Forecast: Market Sizing and Growth Rate
  • Revenue Breakout: Rx versus Dx
  • Targeted Rx and CDx Pricing
  • Publication Hotspot Analyses of the Various Cancer Biomarker Classes for Identifying Niches of Market Opportunity in Various Disease Classes
This data-driven characterization of the Companion Diagnostics and Personalized Medicine field is a hands-on document that can be used for competitive benchmarking, business planning, and strategy development—all the data that have been collected in this industry analysis are presented and they form the basis for the conclusions drawn throughout the market report presented in a format enabling “drag-and-drop” into business presentations/business plans—this Market Report is written and delivered to customers in PowerPoint format.

Extensive Market Analyses Presented in this Report

Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis

  • Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Summary of Pathways to Regulatory Approval of Companion Diagnostics
  • LDTs under CLIA Certification
  • Outcomes with Drugs in Various Disease Classes
  • Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
  • Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
  • How Much Does it Cost to Develop a Companion Diagnostic?
  • Precedent for Premium Pricing in Cancer Targeted Therapeutics
  • Pricing of Selected Personalized Medicine Tests
  • Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate
Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics

Market Trends and Evolution of the CDx Marketplace

  • Disparities between Rx and CDx Companies
  • Varying Economic Incentives between Rx and Dx Development
  • Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
  • Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
  • Cancer Classes Addressable by CDx
  • Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
  • Cancer Biomarkers
  • Oncogenes
  • Tumor Suppressor Genes
  • Non-coding RNAs
Collaborations and Partnering in the CDx Space

  • 2012
  • 2011
  • 2010
  • 2009
Table of Content

Chapter I.  Personalized Medicine and Companion Diagnostics: Market Segmentation and Quantitative Analysis

  • Definition of Companion Diagnostics
  • Classes of Biomarkers and their Utility in Personalized Medicine
  • Prognostic Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Predictive Biomarkers in Cancer Listing, Description, and Clinical Significance
  • Challenges for the Broader Personalized Medicine Field and its Adoption
  • Summary of Pathways to Regulatory Approval of Companion Diagnostics
  • LDTs under CLIA Certification
  • Outcomes with Drugs in Various Disease Classes
  • Percent of Tumor Classes where Tumors are Associated with Characterized Somatic Mutations
  • Somatic Mutation Sequelae in Lung Cancer and Gastrointestinal Cancers
  • Xalkori® Story
  • Zelboraf® Story
  • Companion Diagnostics and Personalized Medicine: Quantitative Market Metrics
  • How Much Does it Cost to Develop a Companion Diagnostic?
  • Precedent for Premium Pricing in Cancer Targeted Therapeutics
  • Pricing of Selected Personalized Medicine Tests
  • Growth of the Personalized Medicine Marketplace: Market Size/Forecast and Growth Rate
Chapter II.  Personalized Medicine Industry Landscape: Selected Indications, Biomarkers and Therapeutics

  • Therapeutic
  • Biomarker
  • Indication
  • Testing Mandate
  • This comprehensive listing frames the various personalized medicine tests that are either “Required”, “Recommended”, “For Information Use Only”, or “With No Pharmacogenomic Information on the Drug Label”
Chapter III.  Market Trends and Evolution of the CDx Marketplace

  • Timeline of Rx/CDx Co-development over the Last Two Decades
  • Disparities between Rx and CDx Companies
  • Varying Economic Incentives between Rx and Dx Development
  • Increasing Targeted Rx in the Oncology Space and Effect on CDx Development
  • Current Rx/CDx Co-development Programs in Phase III Trials with Listing of Associated Biomarkers
  • Cancer Classes Addressable by CDx
  • Characterization of Molecular Biomarker Classes: Hotspot Analysis of Publications
  • Cancer Biomarkers
  • Oncogenes
  • Tumor Suppressor Genes
  • Non-coding RNAs
Collaborations and Partnering in the CDx Space

2012
2011
2010
2009

Appendix I.Research Methodology

Appendix II.Listing and Description of Cancer Biomarkers

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Biotechnology Reagents Market - Global Industry Size, Share, Trends, Analysis and Forecast, 2011 - 2018
By - Transparency Market Research
Biotechnology reagents are the substances or chemical compound that is added to a system to detect, examine or synthesize other substances. Biotechnology industry mainly combines cellular and molecular biotechnology, human immunology and genetics, focusing mainly upon research and innovations in recombinant DNA technology or genetic engineering. Growth of such industries mainly depends on innovative products. Hence, all this attributes growth opportunities for related markets such as reagents, which depends to a large extent on the market for biotechnology industries. Some of...
Wireless USB (WUSB) Devices Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Wireless technology is a rapidly expanding phenomenon in the 21st century. It started with wireless data transfers to wireless net connectivity to LAN/WAN/internet connection as well the modern electronics going the wireless way. Wireless personal area network (WPAN) technologies, Bluetooth, wireless USB which eliminates the need of landline cabled infrastructure while allowing electronic devices to connect and communicate are growing in popularity. WPAN enabled devices are a growing clan in the electronics industry and they mark the era of intelligent inter-device communication....
Smart Education And Learning Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The smart education and learning market is growing substantially as the number of students opting for digital education and distant learning for gaining knowledge and degrees is increasing day by day. The digital education market is widely catering to the need of governments and international standardization bodies for training and developing skilled and educated workforce in various fields.  One of the major factors driving this market is the growing demand from consumers, students, parents, employers or employees, to become digitally educated. Smart education is in...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...